Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Basharat Ahmad Bhat, Ifra Saifi, Nizar A. Khamjan, Syed Suhail Hamdani, Abdullah Algaissi, Safeena Rashid, Mohammed M Alshehri, Showkat Ahmad Ganie, Mohtashim Lohani, Siddig Ibrahim Abdelwahab & Sajad Ahmad Dar. (2023) Exploring the tumor immune microenvironment in ovarian cancer: a way-out to the therapeutic roadmap. Expert Opinion on Therapeutic Targets 0:0.
Read now
Read now
Ana C. Veneziani, Eduardo Gonzalez-Ochoa & Amit M. Oza. (2023) Emerging peptide therapeutics for the treatment of ovarian cancer. Expert Opinion on Emerging Drugs 28:2, pages 129-144.
Read now
Read now
Mi Tang, Jiang-Hui Cai, Hao-Yang Diao, Wen-Mei Guo, Xiao Yang & ShaSha Xing. (2022) The progress of peptide vaccine clinical trials in gynecologic oncology. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Yuming Li, Wenshu Lu, Jiarun Yang, Mark Edwards & Shisong Jiang. (2021) Survivin as a biological biomarker for diagnosis and therapy. Expert Opinion on Biological Therapy 21:11, pages 1429-1441.
Read now
Read now
Heather L. Torrey, Valarmathy Kaliaperumal, Yogesh Bramhecha, Genevieve M. Weir, Ann R. Falsey, Edward E. Walsh, Joanne M. Langley, Bert Schepens, Xavier Saelens & Marianne M. Stanford. (2020) Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein. Human Vaccines & Immunotherapeutics 16:9, pages 2007-2017.
Read now
Read now
Marie-Laurence Tremblay, Zoe O’Brien-Moran, James A. Rioux, Andrea Nuschke, Christa Davis, W. Martin Kast, Genevieve Weir, Marianne Stanford & Kimberly D. Brewer. (2020) Quantitative MRI cell tracking of immune cell recruitment to tumors and draining lymph nodes in response to anti-PD-1 and a DPX-based immunotherapy. OncoImmunology 9:1.
Read now
Read now
Ava Vila-Leahey, Alecia MacKay, Liliana Portales-Cervantes, Genevieve M. Weir, Alexandra Merkx-Jacques & Marianne M. Stanford. (2020) Generation of highly activated, antigen-specific tumor-infiltrating CD8+ T cells induced by a novel T cell-targeted immunotherapy. OncoImmunology 9:1.
Read now
Read now
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan Pol, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial watch: Peptide-based vaccines in anticancer therapy. OncoImmunology 7:12.
Read now
Read now
Lisa D. MacDonald, Alecia MacKay, Valarmathy Kaliaperumal, Genevieve Weir, Andrea Penwell, Rajkannan Rajagopalan, Joanne M. Langley, Scott Halperin, Marc Mansour & Marianne M. Stanford. (2018) Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform. Human Vaccines & Immunotherapeutics 14:1, pages 59-66.
Read now
Read now
Abhishek D. Garg, Sanket More, Nicole Rufo, Odeta Mece, Maria Livia Sassano, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. OncoImmunology 6:12.
Read now
Read now
Adam J. Grippin, Elias J. Sayour & Duane A. Mitchell. (2017) Translational nanoparticle engineering for cancer vaccines. OncoImmunology 6:10.
Read now
Read now
Victor Rodriguez-Freixinos, Helen J. Mackay, Katherine Karakasis & Amit M. Oza. (2016) Current and emerging treatment options in the management of advanced ovarian cancer. Expert Opinion on Pharmacotherapy 17:8, pages 1063-1076.
Read now
Read now
Articles from other publishers (63)
Sahar Dinparvar, Emrah Sefik Abamor, Sedanur Oztav, Tugba Gul Inci, Murat Ihlamur, Malahat Baghirova, Dilek Turgut-Balik & Adil M Allahverdiyev. (2023) Evaluation of in vitro immunostimulatory and cytotoxic effects of recombinant survivin protein in combination with doxorubicin and breast cancer antigen-loaded polycaprolactone nanoparticles. Nano Futures 7:3, pages 035001.
Crossref
Crossref
Nicholas R. Schindler & David A. Braun. (2023) Antigenic targets in clear cell renal cell carcinoma. Kidney Cancer 7:1, pages 81-91.
Crossref
Crossref
Adam S. Chervin, Jennifer D. Stone, Iwona Konieczna, Kelly M. Calabrese, Ningyan Wang, Dipica Haribhai, Feng Dong, Michael K. White, Luis E. Rodriguez, Gail T. Bukofzer, Paul A. Ellis, Cormac Cosgrove, Claudie Hecquet, Jerry D. Clarin, Joann P. Palma & Edward B. Reilly. (2023) ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies. Molecular Cancer Therapeutics 22:8, pages 903-912.
Crossref
Crossref
Oliver Dorigo, Amit M. Oza, Tanja Pejovic, Prafull Ghatage, Sharad Ghamande, Diane Provencher, Lisa D. MacDonald, Heather Torrey, Valarmathy Kaliaperumal, Walead Ebrahimizadeh, Heather A. Hirsch, Yogesh Bramhecha, Jeannine Villella & Stephan Fiset. (2023) Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial. Clinical Cancer Research 29:15, pages 2808-2815.
Crossref
Crossref
Nirjari Kothari, Humzah Postwala, Aanshi Pandya, Aayushi Shah, Yesha Shah & Mehul R. Chorawala. (2023) Establishing the applicability of cancer vaccines in combination with chemotherapeutic entities: current aspect and achievable prospects. Medical Oncology 40:5.
Crossref
Crossref
Paul Schossig, Ebru Coskun, Ruza Arsenic, David Horst, Jalid Sehouli, Eva Bergmann, Nadine Andresen, Christian Sigler, Antonia Busse, Ulrich Keller & Sebastian Ochsenreither. (2023) Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens. International Journal of Molecular Sciences 24:3, pages 2292.
Crossref
Crossref
Julie Healer, Jennifer K. Thompson, Karen L. Mackwell, Cecille D. Browne, Benjamin A. Seager, Anna Ngo, Kym N. Lowes, Sarah E. Silk, David Pulido, Lloyd D. W. King, Jayne M. Christen, Amy R. Noe, Vinayaka Kotraiah, Paul J. Masendycz, Rajkannan Rajagopalan, Leanne Lucas, Marianne M. Stanford, Lorraine Soisson, Carter Diggs, Robin Miller, Susan Youll, Kaye Wycherley, Simon J. Draper & Alan F. Cowman. (2022) RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Meihua Yu, Wei Yang, Wenwen Yue & Yu Chen. (2022) Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation. Advanced Science 9:35.
Crossref
Crossref
Maximilian Haist, Volker Mailänder & Matthias Bros. (2022) Nanodrugs Targeting T Cells in Tumor Therapy. Frontiers in Immunology 13.
Crossref
Crossref
Ruiqing He, Jie Zang, Yuge Zhao, Haiqing Dong & Yongyong Li. (2022) Nanotechnology-Based Approaches to Promote Lymph Node Targeted Delivery of Cancer Vaccines. ACS Biomaterials Science & Engineering 8:2, pages 406-423.
Crossref
Crossref
Takumi Kumai, Hidekiyo Yamaki, Michihisa Kono, Ryusuke Hayashi, Risa Wakisaka & Hiroki Komatsuda. (2022) Antitumor Peptide-Based Vaccine in the Limelight. Vaccines 10:1, pages 70.
Crossref
Crossref
Maritza P. Garrido, Allison N. Fredes, Lorena Lobos-González, Manuel Valenzuela-Valderrama, Daniela B. Vera & Carmen Romero. (2021) Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer. Biomedicines 10:1, pages 77.
Crossref
Crossref
Ling-xiao Zhang & Zhi Ping Xu. 2021. Biomedical Applications of Inorganic Materials. Biomedical Applications of Inorganic Materials
305
360
.
Robert C. Mould, Jacob P. van Vloten, Amanda W. K. AuYeung, Scott R. Walsh, Jondavid de Jong, Leonardo Susta, Anthony J. Mutsaers, James J. Petrik, Geoffrey A. Wood, Sarah K. Wootton, Khalil Karimi & Byram W. Bridle. (2021) Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin. Cancers 13:24, pages 6270.
Crossref
Crossref
Cheryl Lai-Lai Chiang, Raphaël Rovelli, Apostolos Sarivalasis & Lana E. Kandalaft. (2021) Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human. Cancers 13:18, pages 4553.
Crossref
Crossref
Liliana Montella, Federica Sarno, Annamaria Ambrosino, Sergio Facchini, Maria D’Antò, Maria Maddalena Laterza, Morena Fasano, Ermelinda Quarata, Raffaele Angelo Nicola Ranucci, Lucia Altucci, Massimiliano Berretta & Gaetano Facchini. (2021) The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma. Cells 10:8, pages 1909.
Crossref
Crossref
Amrita Basu, Ganesan Ramamoorthi, Gabriella Albert, Corey Gallen, Amber Beyer, Colin Snyder, Gary Koski, Mary L. Disis, Brian J. Czerniecki & Krithika Kodumudi. (2021) Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Joyce Wei, Welby Montalvo-Ortiz, Lola YuAmanda Krasco, Sarah Ebstein, Czrina CortezIsrael Lowy, Andrew J. Murphy, Matthew A. Sleeman & Dimitris Skokos. (2021) Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses. Science Immunology 6:58.
Crossref
Crossref
Brennan S. Dirk, Genevieve Weir, Tara Quinton, Olga Hrytsenko & Marianne M. Stanford. (2021) Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model. Scientific Reports 11:1.
Crossref
Crossref
Stefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, Kinana Habra, Alan Graham Pockley & Stephanie E. B. McArdle. (2021) Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments. Frontiers in Immunology 11.
Crossref
Crossref
Rong En Tay, Emma K. Richardson & Han Chong Toh. (2020) Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms. Cancer Gene Therapy 28:1-2, pages 5-17.
Crossref
Crossref
Linlong Xu, Wenpeng Yu, Han Xiao & Kang Lin. (2021) BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration. Scientific Reports 11:1.
Crossref
Crossref
Craig L Slingluff, Jr., Gina R Petroni, Kimberly A Chianese-Bullock, Nolan A Wages, Walter C Olson, Kelly T Smith, Kathleen Haden, Lynn T Dengel, Anna Dickinson, Caroline Reed, Elizabeth M Gaughan, William W Grosh, Varinder Kaur, Nikole Varhegyi, Mark Smolkin, Nadejda V Galeassi, Donna Deacon & Emily H Hall. (2021) Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63). Journal for ImmunoTherapy of Cancer 9:1, pages e000934.
Crossref
Crossref
Neerada Meenakshi Warrier, Prasoon Agarwal & Praveen Kumar. (2020) Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics. Stem Cell Reviews and Reports 16:5, pages 828-852.
Crossref
Crossref
Zelin Tian, Jianing Tang, Xing Liao, Qian Yang, Yumin Wu & Gaosong Wu. (2020) An immune‐related prognostic signature for predicting breast cancer recurrence. Cancer Medicine 9:20, pages 7672-7685.
Crossref
Crossref
Ahmad Hanif, Sunyoung Lee, Medhavi Gupta, Ankush Chander, Eric D. Kannisto, Achamaporn Punnanitinont, Robert Fenstermaker, Michael Ciesielski, Kristopher Attwood, Jingxin Qiu, Sai Yendamuri & Renuka Iyer. (2020) Exploring the role of survivin in neuroendocrine neoplasms. Oncotarget 11:23, pages 2246-2258.
Crossref
Crossref
Anna Lucia Tornesello, Maria Tagliamonte, Maria Lina Tornesello, Franco M. Buonaguro & Luigi Buonaguro. (2020) Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines. Cancers 12:4, pages 1049.
Crossref
Crossref
Jooeun Bae, Neha Parayath, Wenxue Ma, Mansoor Amiji, Nikhil Munshi & Kenneth C. Anderson. (2019) BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications. Leukemia 34:1, pages 210-223.
Crossref
Crossref
Achraf Noureddine, Jonas G. Croissant, Harrison O. Davis, Lorenza I. Friedrich & Rita E. Serda. 2020. Mucosal Delivery of Drugs and Biologics in Nanoparticles. Mucosal Delivery of Drugs and Biologics in Nanoparticles
177
204
.
Fengzhi Li, Ieman Aljahdali & Xiang Ling. (2019) Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
May Tun Saung, Xiyu Ke, Gregory P. Howard, Lei Zheng & Hai-Quan Mao. (2019) Particulate carrier systems as adjuvants for cancer vaccines. Biomaterials Science 7:12, pages 4873-4887.
Crossref
Crossref
Xiyu Ke, Gregory P. Howard, Haoyu Tang, Bei Cheng, May Tun Saung, José L. Santos & Hai-Quan Mao. (2019) Physical and chemical profiles of nanoparticles for lymphatic targeting. Advanced Drug Delivery Reviews 151-152, pages 72-93.
Crossref
Crossref
Xiangru Feng, Weiguo Xu, Zhongmin Li, Wantong Song, Jianxun Ding & Xuesi Chen. (2019) Immunomodulatory Nanosystems. Advanced Science 6:17.
Crossref
Crossref
Genevieve M. Weir, Lisa D. MacDonald, Rajkannan Rajagopalan, Gloria S. Sivko, Michelle W. Valderas, Jonathan Rayner, Bradley J. Berger, Leeladhar Sammatur & Marianne M. Stanford. (2019) Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillus anthracis spore inhalation challenge. npj Vaccines 4:1.
Crossref
Crossref
Kimberly D. Brewer, Genevieve M. Weir, Iulia Dude, Christa Davis, Cathryn Parsons, Andrea Penwell, Rajkannan Rajagopalan, Leeladhar Sammatur, Chris V. Bowen & Marianne M. Stanford. (2018) Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control. Journal of Biomedical Science 25:1.
Crossref
Crossref
Fanny Onodi, Chahrazed Maherzi-Mechalikh, Alice Mougel, Nadine Ben Hamouda, Charlotte Taboas, Fabien Gueugnon, Thi Tran, Herve Nozach, Elodie Marcon, Alain Gey, Magali Terme, Ahmed Bouzidi, Bernard Maillere, Jérôme Kerzerho, Eric Tartour & Corinne Tanchot. (2018) High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes. Frontiers in Oncology 8.
Crossref
Crossref
Thamara Figueiredo Procópio, Leydianne Leite de Siqueira Patriota, Bárbara Rafaela da Silva Barros, Lethícia Maria de Souza Aguiar, Virgínia Maria Barros de Lorena, Patrícia Maria Guedes Paiva, Cristiane Moutinho Lagos de Melo & Thiago Henrique Napoleão. (2018) Calliandra surinamensis lectin (CasuL) does not impair the functionality of mice splenocytes, promoting cell signaling and cytokine production. Biomedicine & Pharmacotherapy 107, pages 650-655.
Crossref
Crossref
Hua Wang & David J. Mooney. (2018) Biomaterial-assisted targeted modulation of immune cells in cancer treatment. Nature Materials 17:9, pages 761-772.
Crossref
Crossref
Anusha Thadi, Marian Khalili, William Morano, Scott Richard, Steven Katz & Wilbur Bowne. (2018) Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 6:3, pages 54.
Crossref
Crossref
Angelika Terbuch & Juanita Lopez. (2018) Next Generation Cancer Vaccines—Make It Personal!. Vaccines 6:3, pages 52.
Crossref
Crossref
Joanne M Langley, Lisa D MacDonald, Genevieve M Weir, Donna MacKinnon-CameronLingyun YeShelly McNeil, Bert Schepens, Xavier Saelens, Marianne M Stanford & Scott A Halperin. (2018) A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study. The Journal of Infectious Diseases 218:3, pages 378-387.
Crossref
Crossref
Paola Circosta, Katia Vitaggio, Angela Rita Elia, Maja Todorovic, Dario Sangiolo, Fabrizio Carnevale-Schianca, Antonella Vallario, Massimo Geuna, Massimo Aglietta & Alessandro Cignetti. (2018) Survivin-peptide vaccination elicits immune response after allogeneic nonmyeloablative transplantation: a safe strategy to enhance the graft versus tumor effect. Immunotherapy 10:9, pages 753-767.
Crossref
Crossref
Marie-Laurence Tremblay, Christa Davis, Chris V. Bowen, Olivia Stanley, Cathryn Parsons, Genevieve Weir, Mohan Karkada, Marianne M. Stanford & Kimberly D. Brewer. (2018) Using MRI cell tracking to monitor immune cell recruitment in response to a peptide-based cancer vaccine. Magnetic Resonance in Medicine 80:1, pages 304-316.
Crossref
Crossref
Robert A. Fenstermaker, Sheila A. Figel, Jingxin Qiu, Tara A. Barone, Sanam S. Dharma, Evan K. Winograd, Phillip M. Galbo, Laura M. Wiltsie & Michael J. Ciesielski. (2018)
Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth
In Vivo
. Clinical Cancer Research 24:11, pages 2642-2652.
Crossref
Crossref
Elizabeth A. Dubil, Chunqiao Tian, Guisong Wang, Christopher M. Tarney, Nicholas W. Bateman, Douglas A. Levine, Thomas P. Conrads, Chad A. Hamilton, George Larry Maxwell & Kathleen M. Darcy. (2018) Racial disparities in molecular subtypes of endometrial cancer. Gynecologic Oncology 149:1, pages 106-116.
Crossref
Crossref
Rikke Andersen, Marie Christine Wulff Westergaard, Julie Westerlin Kjeldsen, Anja Müller, Natasja Wulff Pedersen, Sine Reker Hadrup, Özcan Met, Barbara Seliger, Bjarne Kromann-Andersen, Thomas Hasselager, Marco Donia & Inge Marie Svane. (2018) T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma—Implications for Adoptive Cell Therapy. Cancer Immunology Research 6:2, pages 222-235.
Crossref
Crossref
Ignazio Puccio, Saif Khan, Adil Butt, David Graham, Vinay Sehgal, Dominic Patel, Marco Novelli, Laurence B. Lovat, Manuel Rodriguez-Justo & Rifat A. Hamoudi. (2018) Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence. International Journal of Experimental Pathology 99:1, pages 10-14.
Crossref
Crossref
Olivier Gasser, Katrina J. Sharples, Catherine Barrow, Geoffrey M. Williams, Evelyn Bauer, Catherine E. Wood, Brigitta Mester, Marina Dzhelali, Graham Caygill, Jeremy Jones, Colin M. Hayman, Victoria A. Hinder, Jerome Macapagal, Monica McCusker, Robert Weinkove, Gavin F. Painter, Margaret A. Brimble, Michael P. Findlay, P. Rod Dunbar & Ian F. Hermans. (2017) A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients. Cancer Immunology, Immunotherapy 67:2, pages 285-298.
Crossref
Crossref
Adrian Bot, Elliot M. Berinstein & Neil L. Berinstein. 2018. Plotkin's Vaccines. Plotkin's Vaccines
161
184.e6
.
Phillip M. GalboJrJr, Michael J. Ciesielski, Sheila Figel, Orla Maguire, Jingxin Qiu, Laura Wiltsie, Hans Minderman & Robert A. Fenstermaker. (2017) Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination. Oncotarget 8:70, pages 114722-114735.
Crossref
Crossref
Michele Graciotti, Cristiana Berti, Harm-Anton Klok & Lana Kandalaft. (2017) The era of bioengineering: how will this affect the next generation of cancer immunotherapy?. Journal of Translational Medicine 15:1.
Crossref
Crossref
Marco Donia, Julie Westerlin Kjeldsen, Rikke Andersen, Marie Christine Wulff Westergaard, Valentina Bianchi, Mateusz Legut, Meriem Attaf, Barbara Szomolay, Sascha Ott, Garry Dolton, Rikke Lyngaa, Sine Reker Hadrup, Andrew K. Sewell & Inge Marie Svane. (2017) PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer. Clinical Cancer Research 23:19, pages 5779-5788.
Crossref
Crossref
Leydianne Leite de Siqueira Patriota, Thamara Figueiredo Procópio, Jéssica de Santana Brito, Virginie Sebag, Ana Patrícia Silva de Oliveira, Ana Karine de Araújo Soares, Leyllane Rafael Moreira, Thâmarah de Albuquerque Lima, Tatiana Soares, Túlio Diego da Silva, Patrícia Maria Guedes Paiva, Virgínia Maria Barros de Lorena, Cristiane Moutinho Lagos de Melo, Lidiane Pereira de Albuquerque & Thiago Henrique Napoleão. (2017) Microgramma vacciniifolia (Polypodiaceae) fronds contain a multifunctional lectin with immunomodulatory properties on human cells. International Journal of Biological Macromolecules 103, pages 36-46.
Crossref
Crossref
Yu-Li Chen, Ming-Cheng Chang & Wen-Fang Cheng. (2017) Metronomic chemotherapy and immunotherapy in cancer treatment. Cancer Letters 400, pages 282-292.
Crossref
Crossref
G. Gravina, C. Wasén, M.J. Garcia-Bonete, M. Turkkila, M.C. Erlandsson, S. Töyrä Silfverswärd, M. Brisslert, R. Pullerits, K.M. Andersson, G. Katona & M.I. Bokarewa. (2017) Survivin in autoimmune diseases. Autoimmunity Reviews 16:8, pages 845-855.
Crossref
Crossref
Genevieve M. Weir, Mohan Karkada, David Hoskin, Marianne M. Stanford, Lisa MacDonald, Marc Mansour & Robert S. Liwski. (2017) Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo. PLOS ONE 12:6, pages e0180073.
Crossref
Crossref
Ulla-Maija Haltia, Noora Andersson, Bhagwan Yadav, Anniina Färkkilä, Evgeny Kulesskiy, Matti Kankainen, Jing Tang, Ralf Bützow, Annika Riska, Arto Leminen, Markku Heikinheimo, Olli Kallioniemi, Leila Unkila-Kallio, Krister Wennerberg, Tero Aittokallio & Mikko Anttonen. (2017) Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells. Gynecologic Oncology 144:3, pages 621-630.
Crossref
Crossref
Genevieve M. Weir, Olga Hrytsenko, Tara Quinton, Neil L. Berinstein, Marianne M. Stanford & Marc Mansour. (2016) Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref
Himani Garg, Prerna Suri, Jagdish C. Gupta, G. P. Talwar & Shweta Dubey. (2016) Survivin: a unique target for tumor therapy. Cancer Cell International 16:1.
Crossref
Crossref
John B. Liao. (2016) Immunotherapy for gynecologic cancers. Gynecologic Oncology 142:1, pages 3-5.
Crossref
Crossref
Kimberly D. Brewer, Drew R. DeBay, Iulia Dude, Christa Davis, Kerry Lake, Cathryn Parsons, Rajkannan Rajagopalan, Genevieve Weir, Marianne M. Stanford, Marc Mansour & Chris V. Bowen. (2016) Using lymph node swelling as a potential biomarker for successful vaccination. Oncotarget 7:24, pages 35655-35669.
Crossref
Crossref
Rasha Abu Eid, Ghazaleh Shoja E. Razavi, Mikayel Mkrtichyan, John Janik & Samir N. Khleif. (2016) Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed. Cancer Immunology Research 4:5, pages 377-382.
Crossref
Crossref
C. Sanhueza, S. Wehinger, J. Castillo Bennett, M. Valenzuela, G. I. Owen & A. F. G. Quest. (2015) The twisted survivin connection to angiogenesis. Molecular Cancer 14:1.
Crossref
Crossref